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Epidemics are not a new event in human history. The Plague
of Athens, one of the earliest documented outbreaks, hit the
city state of Athens in ancient Greece during the Peloponne-
sianWar and killed thousands of people. Bubonic Plague and
Cholera decimated one-third of the European population
over the middle and modern ages. The deadly H1N1 influ-
enza pandemic of 1918 infected more than 500 million peo-
ple and killed almost 5% of the world’s population. As times
change and science evolves, new tools to treat and contain
infectious disease arise. On the one hand, antibiotics, antivi-
rals, and vaccines are routinely available. On the other,
urbanization, social dynamicchanges, andhighmobility allow
for ignition and spread of new pathogens at a much higher
rate. How does an epidemic begin? Where it comes from?
How does it spread? Perhaps as relevant, how can it be
stopped? Recent studies reveal the power of using genomic
data to model and reconstruct the evolution of the two major
threats to human health: the global HIV-1 epidemics and the
very recent outbreak of Ebola virus in West Africa.Interspecies transmission of HIV-1 might have first occurred in
southeastern Cameroon. Fluvial connections between southern
Cameroon and Kinshasa were frequent by that time, and the virus
could have travelled through its host to Kinshasa, where it found
fertile ground for further spread.
Ebola virus, formerly called Zaire ebolavirus, is one of the four
viruses of the genus Ebolavirus that can produce disease in humans,
causing a type of hemorrhagic fever with very high fatality rate.It has been 30 years since HIV-1 was found to be the causa-
tive agent of AIDS (UNAIDS 2013). Still, despite all of the
information gathered about the genetics of the virus, as well
as its simian counterpart, SIV, the initial steps that allowed
the establishment of the virus in human populations remain
enigmatic. It is also illusory why the HIV-1 group M
(for ‘‘major’’) was the only to reach pandemic proportions,
whereasother groups suchasO (for ‘‘outlier’’), N, andP remain
contained in Central Africa. Now, a group led by Oliver Pybus
and Philippe Lemey attempts to understand the early dynamic
of the epidemics, using genomic sequence data already avail-
able in the HIV Sequence Database maintained by the Los
Alamos National Laboratory in New Mexico (Faria et al.,
2014). They analyzed hundreds of samples from group M
viruses from different African locations over the past century,
beginning in the region formerly known as Belgian Congo,
then Zaire and now Democratic Republic of Congo (DRC),
and extended their analysis to neighbor areas. The sequencing
data was assembled to create phylogenetic trees, and a tech-
nique known as ‘‘molecular clock’’ was used to establishwhen
each tree originated and when it produced new branches.They date the ignition of the HIV epidemics as early as 1920
and support the suggestion that the first episode of trans-
mission from chimpanzees to humans happened in the
surrounds of Kinshasa in the early 1900s. The active trans-
portation network available in Africa in the early 20th century,
associated with changes in sexual behavior and iatrogenic
medical interventions, played a major role in creating the
perfect environment for further dissemination of the virus,
which reached Lubumbashi (then Elizabethville) in 1937 and
Mbuji-Mayi in 1939—major areas of mining that were well
served with rail lines. The HIV-1 group M, subtype B, which
accounts for the majority of infections in the United States
and Europe, likely surfaced in Kinshasa by 1944. Interest-
ingly, they find that HIV-1 groups M and O expanded at
similar rates until 1960. Though it is still unclear why group
M outpaced group O and became predominant, this study
brings our understanding of the early events in the HIV epi-
demics to a much higher level of resolution and provides a
perspective on how social and economic changes are big
players in the emergence of new infectious agents.
Reconstructing the history of an epidemic that began
almost a century ago has its own challenges. What about
using genomic surveillance to understand an outbreak as
it unveils? The 2014 outbreak of the deadly Ebola virus
began in February in Guinea and quickly spread through
Guinea, Liberia, Sierra Leone, and Nigeria (Baize et al.,
2014). It is the largest Ebola outbreak ever known, and
first cases in the United States and Europe, imported from
Africa, are now confirmed. To understand the origins of the
virus and its transmission chain in the current outbreak, a
multinational team led by Pardis Sabeti at Harvard University
sequenced the genome of the Ebola virus from samples of
78 patients from Sierra Leone who died or were infected
with the 2014 virus, combined their data with previously pub-
lished libraries, and reconstructed the spread of the outbreak
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The analysis suggests that a single event of transmission
from an Ebola natural reservoir into a human triggered the
whole process. Molecular dating places the ancestor virus
of the sequenced isolates around late February 2014, near
when the first cases were confirmed in Guinea. Epidemiolog-
ical investigations traced the initial cases in Sierra Leone to
a burial ceremony of a traditional healer who had treated
patients with Ebola in Guinea. Two genetically distinct
viruses circulating in Guinea were introduced in Sierra Leone
simultaneously in late May 2014. All subsequent viral diver-
sity in Sierra Leone accumulated from the two original viral
backbones, showing that, in opposition to previous Ebola
outbreaks, continued human-reservoir exposure did not
contribute to growth of the epidemics. As always happens
with Ebola virus, the new outbreak is accompanied by ex-
tensive genetic changes in the virus. Whether these new
mutations contribute to high lethality observed in this epi-
demics and whether additional mutations have emerged
since the first Sierra Leonean isolates remains to be deter-
mined. Further studies will require access and sequencing
of more samples from later stages of the epidemics.
Studies such as these two might not be able to prevent
future outbreaks. However, the ability to gather genomic
data and combine it with epidemiological vigilance and
modeling might teach us how to prepare and perhaps how
to interrupt the chain of events before it is too late.
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